welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
The 2021 Scientific Workshop will be a hybrid virtual and in-person event to maximize opportunities for in-person collaboration while facilitating meaningful participation from those unable to travel. This one day event will include a combination of session formats designed to include expert panels, case study presentations from rare disease stakeholders, and robust discussion sessions to create actionable recommendations.
• Identify the research, regulatory and access policy barriers to increasing the utilization of the Accelerated Approval pathway for rare disease therapeutic development by examining a series of real-world case studies.
• Generate a 1, 3- and 5-year action plan for how the Accelerated Approval pathway can be optimized to meet the critical need for new rare disease therapies.
Date & Time:
Wednesday, October 20, 2021
9:00 AM to 4:00 PM EST
Thyroid Eye Disease Drug Meets Primary Endpoint for Proptosis ReductionTop-line results from the OPTIC trial sh...
Graves’ Disease After Treatment With Alemtuzumab for Multiple SclerosisContext: Alemtuzumab, a humanized monoc...
Thyroid Disease and Coronavirus (COVID-19)COVID-19 is a new illness that can affec...
Hyperthyroidism and Your HeartHyperthyroidism occurs when your thyroid...
Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients With HyperthyroidismObjective: The purpose of this study wa...
The Brazilian Consensus for the Diagnosis and Treatment of Hyperthyroidism: Recommendations by the Thyroid Departmen...Introduction: Hyperthyroidism is charac...
University of California San Francisco (UCSF) Thyroid and Parathyroid Surgery ClinicUniversity of California San Francisco (...